Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Cipla
Dow
US Department of Justice
Medtronic
Colorcon
Queensland Health
Argus Health

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,324,283

« Back to Dashboard

Which drugs does patent 8,324,283 protect, and when does it expire?

Patent 8,324,283 protects GILENYA and is included in one NDA.

Protection for GILENYA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has ninety-two patent family members in forty-two countries.
Summary for Patent: 8,324,283
Title:Solid pharmaceutical compositions comprising a SIP receptor agonist and a sugar alcohol
Abstract: A solid pharmaceutical composition suitable for oral administration, comprising: (a) a S1P receptor agonist; and (b) a sugar alcohol.
Inventor(s): Oomura; Tomoyuki (Oita, JP), Pudipeddi; Madhusudhan (Edison, NJ), Ruegger; Colleen (Morris Plains, NJ), Royce; Alan E (Saylorsburg, PA), Sasaki; Masaki (Oita, JP), Tamura; Tokuhiro (Fukuoka, JP)
Assignee: Novartis AG (Basel, CH) Mitsubishi Pharma Corporation (Osaka, JP)
Application Number:12/189,323
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,324,283
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form; Use;

Drugs Protected by US Patent 8,324,283

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Novartis GILENYA fingolimod CAPSULE;ORAL 022527-001 Sep 21, 2010 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 8,324,283

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Russian Federation 2005134173 ➤ Try a Free Trial
Portugal 1613288 ➤ Try a Free Trial
Poland 2316431 ➤ Try a Free Trial
Peru 13522013 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Colorcon
McKesson
AstraZeneca
US Army
Queensland Health
Mallinckrodt
Express Scripts
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.